eltrombopag olainfarm õhukese polümeerikattega tablett
olainfarm as - eltrombopaag - õhukese polümeerikattega tablett - 12,5mg 84tk; 12,5mg 10tk; 12,5mg 28tk; 12,5mg 30tk; 12,5mg 14tk
eltrombopag olainfarm õhukese polümeerikattega tablett
olainfarm as - eltrombopaag - õhukese polümeerikattega tablett - 50mg 14tk
eltrombopag olainfarm õhukese polümeerikattega tablett
olainfarm as - eltrombopaag - õhukese polümeerikattega tablett - 25mg 84tk; 25mg 28tk; 25mg 10tk
eltrombopag olainfarm õhukese polümeerikattega tablett
olainfarm as - eltrombopaag - õhukese polümeerikattega tablett - 75mg 14tk; 75mg 28tk; 75mg 84tk
purevax rcpch
boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated chlamydophila felis (905 strain), attenuated feline panleucopenia virus (pli iv) - immunoloogilised ravimid jaoks felidae, - kassid - active immunisation of cats aged eight weeks and older:• against feline viral rhinotracheitis to reduce clinical signs;• against calicivirus infection to reduce clinical signs;• against chlamydophila felis infection to reduce clinical signs;• against feline panleucopenia to prevent mortality and clinical signs. immuunsuse tagajärgi on tõestatud üks nädal pärast esmast vaktsinatsioonikursust rinotrahheiidi, kalitsiviiruse, chlamydophila felis ja panleukopeenia komponentide jaoks. the duration of immunity is one year after the last re-vaccination for the chlamydiosis component, and oneyear after primary vaccination and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.
purevax rcch
merial - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated chlamydophila felis (905 strain) - immunoloogilised ravimid jaoks felidae, - kassid - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs and excretion;against chlamydophila felis infection to reduce clinical signs. immuunsuse tekkekohad on tõestatud 1 nädala jooksul pärast esmast vaktsinatsioonikursust rinotrahheiidi, kalitsiviiruse ja chlamydophila felis komponentide jaoks. immuunsuse kestus on 1 aasta pärast viimast (uuesti) vaktsineerimist.
ropinirole portfarma 8 mg toimeainet prolongeeritult vabastav tablett
portfarma ehf. - ropinirool - toimeainet prolongeeritult vabastav tablett - 8mg 90tk; 8mg 30tk; 8mg 42tk; 8mg 7tk; 8mg 21tk
ibandronic acid portfarma õhukese polümeerikattega tablett
portfarma ehf - ibandroonhape - õhukese polümeerikattega tablett - 150mg 1tk; 150mg 3tk
ropinirole portfarma 2 mg toimeainet prolongeeritult vabastav tablett
portfarma ehf. - ropinirool - toimeainet prolongeeritult vabastav tablett - 2mg 90tk; 2mg 7tk; 2mg 100tk; 2mg 21tk; 2mg 28tk; 2mg 30tk
escitalopram portfarma õhukese polümeerikattega tablett
portfarma ehf. - estsitalopraam - õhukese polümeerikattega tablett - 5mg 30tk; 5mg 100tk; 5mg 500tk; 5mg 28tk; 5mg 98tk; 5mg 20tk; 5mg 56tk